This drug had not previously been considered by the PBAC for this indication. Osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific ...

Alendronate (Osteofos (70 mg)) is used to treat or prevent osteoporosis or bone thinning in men and post-menopausal women and Paget's disease or bone deformity. It is also recommended for patients ...

The US Food and Drug Administration has granted tentative approval for Teva Pharmaceutical Industries’s ANDA for Alendronate Sodium Tablets, 5 milograms (mg), 10 mg, 35 mg, 40 mg and 70 mg.

CORONA, Calif., Feb. 5 -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the company expects to initiate shipments of alendronate sodium in ...

Fosamax (alendronate) is now available in a 70-mg formulation. Are there any differences in alendronate formulation between the 10-mg tablet and the new 70-mg tablet? My question is prompted by a ...

Alendronate sodium is a bisphosphonate used to treat Paget disease of bone (PDB). The approved dosage of 40 mg/day for 6 months is generally well tolerated, but esophageal irritation can occur if the ...

Satellite radio's "ReachMD," and the "Balancing Act" on Lifetime Television Focus on Breakthrough Treatment for Osteoporosis and Patients Who Have Difficulty Swallowing Pills. About half of all women ...